$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Tissue engineering emerged in the 1980s to create living tissue substitutes, and potentially address significant organ and tissue shortages1. One strategy has used scaffolds to stimulate and guide the body to regenerate missing tissues or organs. Although advanced manufacturing approaches such as 3-D printing have produced scaffolds with unique physical properties, the ability to manufacture scaffolds with a diverse range of achievable physical and biological properties remains a challenge2,3. Moreover, due to a lack of a functional vascular network, these techniques have been limited in regenerating 3-dimensional tissues. The use of decellularized animal and human tissues as scaffolds has aided in circumventing this problem4,5,6,7. However, high cost, batch-to-batch variability, and limited availability may limit widespread use of decellularized animal scaffolds8. There are also concerns about potential disease transmission to patients and immunologic reaction to some decellularized mammalian tissues9.
Cellulose, derived from plant and bacterial sources, has been extensively used to generate biomaterials for a wide range of applications in regenerative medicine. Some examples include: bone10,11, cartilage12,13,14 and wound healing15. Scaffolds that are comprised of cellulose have an added benefit in that they are durable and resistant to being broken down by mammalian cells. This is due to the fact that mammalian cells do not produce the enzymes necessary to break down cellulose molecules. In comparison, scaffolds produced using macromolecules from the extracellular matrix, such as collagen, are readily broken down16 and may not be well suited to long-term applications. Collagen scaffolds can be stabilized by chemical cross-linking. However, there is a trade-off due to the inherent toxicity of the cross-linkers that affect the biocompatibility of the scaffolds17. Conversely, cellulose has the potential to remain present at the site of implantation for prolonged periods of time because it is impervious to enzymatic degradation by mammalian cells18,19,20. This can be altered by tuning the rate of degradation through hydrolysis pretreatment and co-delivery of the scaffolds with cellulases21. The biocompatibility of decellularized plant-derived cellulose scaffolds in vivo has also been demonstrated in a study done on mice22.
Through hundreds of millions of years of evolution, plants have refined their structure and composition to increase the efficiency of fluid transport and retention. Plant vascular vessels minimize hydraulic resistance by branching into smaller vessels, similar to the mammalian vasculature according to Murray's law23. After decellularization, the plant's complex network of vessels and interconnected pores is maintained. Considering the vast number of distinct plant species readily available, plant-derived scaffolds have the potential to overcome design limitations currently affecting scaffolds in tissue engineering24,25. For instance, Modulevsky et al. demonstrated that angiogenesis and cell migration occurred when decellularized apple tissue was implanted subcutaneously on the back of a mouse22. Similarly, Gershlak et al. showed that endothelial cells could be grown within the vasculature of decellularized leaves24. In a separate experiment, Gershlak et al. were also able to show that cardiomyocytes could be grown on the surface of leaves and were able to contract24.
Plants also include complex organization from the cellular to the macroscopic scale, which is difficult to achieve even with the most advanced manufacturing techniques developed to date. The complex hierarchical design of plant tissues makes them stronger than the sum of their constituents26. Plants possess a plethora of different mechanical properties ranging from rigid and tough components such as stems, to much more flexible and pliable ones such as leaves27. Leaves vary depending on species in terms of size, shape, break strength, the degree of vascularization, and can carry different degrees of hydrophilicity. Overall, these plant properties suggest that decellularized plants can serve as unique and highly functional medical devices, including as tissue engineering scaffolds.
This protocol focuses on two methods to decellularize plant tissues, such as leaves and stems, for use as scaffolds in tissue engineering. The first method is a detergent-based technique that uses a series of baths to remove DNA and cellular matter, which has been adapted from a widely used technique to decellularize mammalian and plant tissues6,22,25,28,29,30. The second method is detergent-free and is adapted from a "skeletonization" protocol generally used to remove the soft tissues of leaves31. Prior work showed that simmering leaves in a bleach and sodium bicarbonate solution facilitated separation of the vasculature from the surrounding soft tissue31. This technique can be cited back to experiments carried out in the 17th and 18th centuries, such as the work of Albertus Seba32 and Edward Parrish33. These experiments centered around leaving plant matter, such as leaves and fruit, submerged in water for extended periods of time (weeks to months) and allowing the softer tissues to decay away naturally. Here the "skeletonization" approach is adapted to use milder conditions, such as longer incubation times at lower temperatures, to remove cellular residues and to avoid significantly disrupting the soft tissue structure. For the experiments detailed herein, three plant types were used: Ficus hispida, Pachira aquatica and a species of Garcinia. Results of DNA quantification, mechanical tests, and impact on cellular metabolic activity from both methods are described.